211 related articles for article (PubMed ID: 8221257)
1. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy.
Zimmerman B; Lanner A; Enander I; Zimmerman RS; Peterson CG; Ahlstedt S
Clin Exp Allergy; 1993 Jul; 23(7):564-70. PubMed ID: 8221257
[TBL] [Abstract][Full Text] [Related]
2. Asthma in children less than 5 years of age: eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms.
Zimmerman B; Enander I; Zimmerman R; Ahlstedt S
Clin Exp Allergy; 1994 Feb; 24(2):149-55. PubMed ID: 8187030
[TBL] [Abstract][Full Text] [Related]
3. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.
Wever AM; Wever-Hess J; Hermans J
Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426
[TBL] [Abstract][Full Text] [Related]
4. Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a 6-month follow-up study.
Wojnarowski C; Roithner B; Koller DY; Halmerbauer G; Gartner C; Tauber E; Frischer T
Clin Exp Allergy; 1999 Jul; 29(7):926-32. PubMed ID: 10383593
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of monitoring eosinophil activity in asthma.
Koller DY; Herouy Y; Götz M; Hagel E; Urbanek R; Eichler I
Arch Dis Child; 1995 Nov; 73(5):413-7. PubMed ID: 8554357
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy.
Scher H; Berman D; Weinberg EG; Schinkel M; Peper B; Chalton DO; Potter PC
Clin Exp Allergy; 1996 Oct; 26(10):1131-41. PubMed ID: 8911698
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
[TBL] [Abstract][Full Text] [Related]
8. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment.
Kristjánsson S; Strannegård IL; Strannegård O; Peterson C; Enander I; Wennergren G
J Allergy Clin Immunol; 1996 Jun; 97(6):1179-87. PubMed ID: 8648010
[TBL] [Abstract][Full Text] [Related]
9. The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma.
Prehn A; Seger RA; Faber J; Torresani T; Molinari L; Gerber A; Sennhauser FH
Pediatr Allergy Immunol; 1998 Nov; 9(4):197-203. PubMed ID: 9920218
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma.
Ferguson AC; Vaughan R; Brown H; Curtis C
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):23-8. PubMed ID: 7822660
[TBL] [Abstract][Full Text] [Related]
11. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.
Pedersen B; Dahl R; Larsen BB; Venge P
Allergy; 1993 Jul; 48(5):377-82. PubMed ID: 8103646
[TBL] [Abstract][Full Text] [Related]
12. Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: the influence of atopy.
Remes S; Korppi M; Remes K; Savolainen K; Mononen I; Pekkanen J
Pediatr Pulmonol; 1998 Mar; 25(3):167-74. PubMed ID: 9556008
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
[TBL] [Abstract][Full Text] [Related]
14. Serum eosinophil cationic protein (ECP) as a mediator of inflammation in acute asthma, during resolution and during the monitoring of stable asthmatic patients treated with inhaled steroids according to a dose reduction schedule.
Kunkel G; Rydén AC
Inflamm Res; 1999 Feb; 48(2):94-100. PubMed ID: 10202995
[TBL] [Abstract][Full Text] [Related]
15. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma.
Vatrella A; Ponticiello A; Parrella R; Romano L; Zofra S; DiLeva A; Bariffi F
Allergy; 1996 Aug; 51(8):547-55. PubMed ID: 8874658
[TBL] [Abstract][Full Text] [Related]
16. Serum eosinophil cationic protein and bronchial hyperresponsiveness to hypoosmolar challenge in naive atopic asthmatics.
Dal Negro R; Tognella S; Micheletto C; Pomari C; Burti E; Mauroner L; Turco P
J Investig Allergol Clin Immunol; 1998; 8(5):294-9. PubMed ID: 9827426
[TBL] [Abstract][Full Text] [Related]
17. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma?
Koller DY; Halmerbauer G; Frischer T; Roithner B
Clin Exp Allergy; 1999 Jun; 29(6):786-93. PubMed ID: 10336595
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
19. [Effect of triamcinolone acetonide, montelukast, nedocromil sodium and formoterol on eosinophil blood counts, ECP serum levels and clinical progression of asthma in children].
Stelmach I; Grzelewski T; Stelmach W; Majak P; Jerzyńska J; Górski P; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):208-13. PubMed ID: 12053590
[TBL] [Abstract][Full Text] [Related]
20. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up.
Belda J; Giner J; Casan P; Sanchis J
Chest; 2001 Apr; 119(4):1011-7. PubMed ID: 11296162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
